Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells

Ming-Ying Lan,1,2 Yen-Bin Hsu,1,2 Ming-Chin Lan,3,4 Jyh-Ping Chen,5– 8 Yu-Jen Lu9 1Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan; 2School of Medicine, National Yang-Ming University, Taipei, Taiwan; 3Department of Otolaryngology-Head an...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lan MY, Hsu YB, Lan MC, Chen JP, Lu YJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	nasopharyngeal carcinoma anti-cancer graphene oxide erlotinib drug carrier Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/2bfebd12251d4d8d9666090cee0b9ceb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2bfebd12251d4d8d9666090cee0b9ceb
record_format	dspace
spelling	oai:doaj.org-article:2bfebd12251d4d8d9666090cee0b9ceb2021-12-02T11:14:06ZPolyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells1178-2013https://doaj.org/article/2bfebd12251d4d8d9666090cee0b9ceb2020-10-01T00:00:00Zhttps://www.dovepress.com/polyethylene-glycol-coated-graphene-oxide-loaded-with-erlotinib-as-an--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Ming-Ying Lan,1,2 Yen-Bin Hsu,1,2 Ming-Chin Lan,3,4 Jyh-Ping Chen,5– 8 Yu-Jen Lu9 1Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan; 2School of Medicine, National Yang-Ming University, Taipei, Taiwan; 3Department of Otolaryngology-Head and Neck Surgery, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; 4School of Medicine, Tzu Chi University, Hualien, Taiwan; 5Department of Chemical and Materials Engineering, Chang Gung University, Taoyuan, Taiwan; 6Department of Plastic and Reconstructive Surgery and Craniofacial Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan; 7Research Center for Food and Cosmetic Safety, Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan, Taiwan; 8Department of Materials Engineering, Ming Chi University of Technology, Taipei, Taiwan; 9Department of Neurosurgery, Chang Gung Memorial Hospital Linkuo Medical Center and College of Medicine, Chang Gung University, Taoyuan, TaiwanCorrespondence: Yu-Jen LuDepartment of Neurosurgery, Chang Gung Memorial Hospital Linkuo Medical Center and College of Medicine, Chang Gung University, Taoyuan, TaiwanEmail alexlu0416@gmail.comJyh-Ping ChenDepartment of Chemical and Materials Engineering, Chang Gung University, Taoyuan, TaiwanEmail jpchen@mail.cgu.edu.twIntroduction: Nasopharyngeal carcinoma (NPC) is a common cancer in southern China and Taiwan, and radiation therapy combined with or without chemotherapy is its mainstay treatment. Although it is highly sensitive to radiotherapy, local recurrence and distant metastasis remain difficult unsolved problems. In recent years, graphene oxide (GO) has been found to be a promising novel anticancer drug carrier. Here, we present our designed functionalized GO, polyethylene glycol-coated GO (GO-PEG), as a drug carrier, which was loaded with erlotinib and showed promising anticancer effects on NPC cells.Methods: The effects of GO-PEG-erlotinib on the proliferation, migration, and invasion of NPC cells were investigated by WST-8 assay, wound healing assay, and invasion assay, respectively. RNA sequencing was conducted and analyzed to determine the molecular mechanisms by which GO-PEG-erlotinib affects NPC cells.Results: Our results showed that GO-PEG-erlotinib reduced NPC cell viability in a dose-dependent manner and also inhibited the migration and invasion of NPC cells. The RNA sequencing revealed several related molecular mechanisms.Conclusion: GO-PEG-erlotinib effectively suppressed NPC cell proliferation, migration, and invasion, likely by several mechanisms. GO-PEG-erlotinib may be a potential therapeutic agent for treating NPC in the future.Keywords: nasopharyngeal carcinoma, anti-cancer, graphene oxide, erlotinib, drug carrierLan MYHsu YBLan MCChen JPLu YJDove Medical Pressarticlenasopharyngeal carcinomaanti-cancergraphene oxideerlotinibdrug carrierMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 7569-7582 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	nasopharyngeal carcinoma anti-cancer graphene oxide erlotinib drug carrier Medicine (General) R5-920
spellingShingle	nasopharyngeal carcinoma anti-cancer graphene oxide erlotinib drug carrier Medicine (General) R5-920 Lan MY Hsu YB Lan MC Chen JP Lu YJ Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
description	Ming-Ying Lan,1,2 Yen-Bin Hsu,1,2 Ming-Chin Lan,3,4 Jyh-Ping Chen,5– 8 Yu-Jen Lu9 1Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan; 2School of Medicine, National Yang-Ming University, Taipei, Taiwan; 3Department of Otolaryngology-Head and Neck Surgery, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; 4School of Medicine, Tzu Chi University, Hualien, Taiwan; 5Department of Chemical and Materials Engineering, Chang Gung University, Taoyuan, Taiwan; 6Department of Plastic and Reconstructive Surgery and Craniofacial Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan; 7Research Center for Food and Cosmetic Safety, Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan, Taiwan; 8Department of Materials Engineering, Ming Chi University of Technology, Taipei, Taiwan; 9Department of Neurosurgery, Chang Gung Memorial Hospital Linkuo Medical Center and College of Medicine, Chang Gung University, Taoyuan, TaiwanCorrespondence: Yu-Jen LuDepartment of Neurosurgery, Chang Gung Memorial Hospital Linkuo Medical Center and College of Medicine, Chang Gung University, Taoyuan, TaiwanEmail alexlu0416@gmail.comJyh-Ping ChenDepartment of Chemical and Materials Engineering, Chang Gung University, Taoyuan, TaiwanEmail jpchen@mail.cgu.edu.twIntroduction: Nasopharyngeal carcinoma (NPC) is a common cancer in southern China and Taiwan, and radiation therapy combined with or without chemotherapy is its mainstay treatment. Although it is highly sensitive to radiotherapy, local recurrence and distant metastasis remain difficult unsolved problems. In recent years, graphene oxide (GO) has been found to be a promising novel anticancer drug carrier. Here, we present our designed functionalized GO, polyethylene glycol-coated GO (GO-PEG), as a drug carrier, which was loaded with erlotinib and showed promising anticancer effects on NPC cells.Methods: The effects of GO-PEG-erlotinib on the proliferation, migration, and invasion of NPC cells were investigated by WST-8 assay, wound healing assay, and invasion assay, respectively. RNA sequencing was conducted and analyzed to determine the molecular mechanisms by which GO-PEG-erlotinib affects NPC cells.Results: Our results showed that GO-PEG-erlotinib reduced NPC cell viability in a dose-dependent manner and also inhibited the migration and invasion of NPC cells. The RNA sequencing revealed several related molecular mechanisms.Conclusion: GO-PEG-erlotinib effectively suppressed NPC cell proliferation, migration, and invasion, likely by several mechanisms. GO-PEG-erlotinib may be a potential therapeutic agent for treating NPC in the future.Keywords: nasopharyngeal carcinoma, anti-cancer, graphene oxide, erlotinib, drug carrier
format	article
author	Lan MY Hsu YB Lan MC Chen JP Lu YJ
author_facet	Lan MY Hsu YB Lan MC Chen JP Lu YJ
author_sort	Lan MY
title	Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
title_short	Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
title_full	Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
title_fullStr	Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
title_full_unstemmed	Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
title_sort	polyethylene glycol-coated graphene oxide loaded with erlotinib as an effective therapeutic agent for treating nasopharyngeal cancer cells
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/2bfebd12251d4d8d9666090cee0b9ceb
work_keys_str_mv	AT lanmy polyethyleneglycolcoatedgrapheneoxideloadedwitherlotinibasaneffectivetherapeuticagentfortreatingnasopharyngealcancercells AT hsuyb polyethyleneglycolcoatedgrapheneoxideloadedwitherlotinibasaneffectivetherapeuticagentfortreatingnasopharyngealcancercells AT lanmc polyethyleneglycolcoatedgrapheneoxideloadedwitherlotinibasaneffectivetherapeuticagentfortreatingnasopharyngealcancercells AT chenjp polyethyleneglycolcoatedgrapheneoxideloadedwitherlotinibasaneffectivetherapeuticagentfortreatingnasopharyngealcancercells AT luyj polyethyleneglycolcoatedgrapheneoxideloadedwitherlotinibasaneffectivetherapeuticagentfortreatingnasopharyngealcancercells
_version_	1718396102333431808

Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells

Ejemplares similares